NCT02124395View on ClinicalTrials.gov

Health-related Quality of Life in Rare Kidney Stone

CompletedOBSERVATIONAL
Enrollment

365

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
Primary HyperoxaluriaCystinuriaAdenine Phosphoribosyl Transferase DeficiencyDent Disease
Interventions
OTHER

Health-related Quality of Life in Rare Kidney Stone Questionnaire

Trial Locations (3)

55905

Primary Hyperoxaluria and Dent Disease Registry - Mayo Clinic, Rochester

1001+

New York University School of Medicine - Cystinuria Registry, New York

Unknown

APRT Registry - Landspitali Universtiy Hospital, Reykjavik

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

NYU Langone Health

OTHER

NCT02124395 - Health-related Quality of Life in Rare Kidney Stone | Biotech Hunter | Biotech Hunter